According to Dataintelo, the global anti-anxiety drugs market is poised for substantial growth, projected to reach USD 23.8 billion by 2032, growing at a CAGR of 5.4% from 2024 to 2032. Increasing mental health awareness, coupled with rising cases of anxiety disorders, is one of the primary drivers of this market. Governments and private healthcare providers worldwide are expanding access to...